David A. Siegel Care Dx, Inc. Transaction History

Two Sigma Advisers, LP

$41.3 Billion
Q4 2024

A detailed history of David A. Siegel (Two Sigma Advisers, LP) transactions in Care Dx, Inc. stock. As of the latest transaction made, Two Sigma Advisers, LP holds 398,000 shares of CDNA stock, worth $8.82 Million. This represents 0.02% of its overall portfolio holdings.

Number of Shares

398,000

Previous 258,300 54.08%

Holding current value

$8.82 Million

Previous $8.06 Million 5.67%

% of portfolio

0.02%

Previous 0.02%

29 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2024 Feb 14, 2025	BUY	$20.4 - $32.2 $2.85 Million - $4.5 Million	139,700 Added 54.08%	398,000 $8.52 Million
Q3 2024 Nov 14, 2024	BUY	$14.41 - $33.99 $1.68 Million - $3.96 Million	116,500 Added 82.16%	258,300 $8.06 Million
Q2 2024 Aug 14, 2024	SELL	$7.56 - $16.15 $347,004 - $741,284	-45,900 Reduced 24.45%	141,800 $2.2 Million
Q1 2024 May 15, 2024	SELL	$7.96 - $12.37 $327,952 - $509,643	-41,200 Reduced 18.0%	187,700 $1.99 Million
Q4 2023 Feb 14, 2024	SELL	$4.9 - $12.86 $255,290 - $670,006	-52,100 Reduced 18.54%	228,900 $2.75 Million
Q3 2023 Nov 14, 2023	SELL	$7.0 - $11.26 $856,800 - $1.38 Million	-122,400 Reduced 30.34%	281,000 $1.97 Million
Q2 2023 Aug 14, 2023	SELL	$7.61 - $9.46 $570,750 - $709,500	-75,000 Reduced 15.68%	403,400 $3.43 Million
Q1 2023 May 15, 2023	SELL	$8.83 - $17.61 $255,187 - $508,929	-28,900 Reduced 5.7%	478,400 $4.37 Million
Q4 2022 Feb 14, 2023	SELL	$10.88 - $20.05 $907,392 - $1.67 Million	-83,400 Reduced 14.12%	507,300 $5.79 Million
Q3 2022 Nov 14, 2022	BUY	$16.06 - $26.39 $3.4 Million - $5.59 Million	211,700 Added 55.86%	590,700 $10.1 Million
Q2 2022 Aug 15, 2022	BUY	$20.49 - $39.72 $3.58 Million - $6.94 Million	174,800 Added 85.6%	379,000 $8.14 Million
Q1 2022 May 16, 2022	SELL	$28.19 - $46.6 $81,751 - $135,140	-2,900 Reduced 1.4%	204,200 $7.55 Million
Q4 2021 Feb 14, 2022	BUY	$41.2 - $73.6 $1.36 Million - $2.43 Million	33,000 Added 18.95%	207,100 $9.42 Million
Q3 2021 Nov 15, 2021	SELL	$59.15 - $91.99 $2.15 Million - $3.35 Million	-36,400 Reduced 17.29%	174,100 $11 Million
Q2 2021 Aug 16, 2021	SELL	$63.02 - $95.11 $7.78 Million - $11.7 Million	-123,400 Reduced 36.96%	210,500 $19.3 Million
Q1 2021 May 17, 2021	BUY	$57.62 - $95.6 $4.32 Million - $7.17 Million	75,000 Added 28.97%	333,900 $22.7 Million
Q4 2020 Feb 16, 2021	BUY	$41.43 - $77.09 $567,591 - $1.06 Million	13,700 Added 5.59%	258,900 $18.8 Million
Q3 2020 Nov 16, 2020	BUY	$30.88 - $37.94 $4.03 Million - $4.95 Million	130,500 Added 113.78%	245,200 $9.3 Million
Q2 2020 Aug 14, 2020	SELL	$18.95 - $35.43 $644,300 - $1.2 Million	-34,000 Reduced 22.86%	114,700 $4.06 Million
Q1 2020 May 15, 2020	SELL	$13.94 - $28.25 $1.8 Million - $3.65 Million	-129,200 Reduced 46.49%	148,700 $3.25 Million
Q4 2019 Feb 14, 2020	SELL	$19.24 - $28.41 $6.31 Million - $9.32 Million	-328,100 Reduced 54.14%	277,900 $5.99 Million
Q3 2019 Nov 14, 2019	SELL	$20.03 - $40.08 $626,939 - $1.25 Million	-31,300 Reduced 4.91%	606,000 $13.7 Million
Q2 2019 Aug 14, 2019	SELL	$25.78 - $39.77 $56,716 - $87,494	-2,200 Reduced 0.34%	637,300 $22.9 Million
Q1 2019 May 15, 2019	BUY	$22.09 - $39.21 $2.01 Million - $3.57 Million	91,000 Added 16.59%	639,500 $20.2 Million
Q4 2018 Feb 14, 2019	SELL	$19.89 - $30.02 $171,054 - $258,172	-8,600 Reduced 1.54%	548,500 $13.8 Million
Q3 2018 Nov 14, 2018	BUY	$12.1 - $28.85 $1.74 Million - $4.15 Million	143,900 Added 34.83%	557,100 $16.1 Million
Q2 2018 Aug 14, 2018	BUY	$7.93 - $15.79 $2.86 Million - $5.7 Million	360,700 Added 687.05%	413,200 $5.06 Million
Q1 2018 May 15, 2018	BUY	$5.18 - $7.97 $197,876 - $304,454	38,200 Added 267.13%	52,500 $418,000
Q4 2017 Feb 14, 2018	BUY	$3.98 - $7.37 $56,914 - $105,391	14,300	14,300 $105,000

Others Institutions Holding CDNA

# of Institutions

216

Shares Held

53.3M

Call Options Held

53.5K

Put Options Held

23.9K

View Full List

About CareDx, Inc.

Ticker CDNA
Exchange NASDAQ
Sector Healthcare
Industry Diagnostics & Research
Shares Outstandng 53,458,100
Market Cap $1.18B
Description
CareDx, Inc. discovers, develops, and commercializes diagnostic solutions for transplant patients and caregivers worldwide. It provides AlloSure Kidney, a donor-derived cell-free DNA (dd-cfDNA) solution for kidney transplant patients; AlloMap Heart, a gene expression solution for heart transplant patients; AlloSure Heart, a dd-cfDNA solution for...

More about CDNA

Track David A. Siegel's Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Two Sigma Advisers, LP, based on Form 13F filings with the SEC.

News

Stay updated on Two Sigma Advisers, LP and David A. Siegel with notifications on news.

Account